to further study the effectiveness and safety of its psychedelic formulation. This would require additional funding as well as a number of... and (5) a full array of tailored corporate ...

Psychedelics are being tested as add-ons to psychotherapy, but in trials, there's little detail about how the therapy is actually conducted, Dr. Albino Oliveira-Maia says.

MDMA-assisted therapy for post-traumatic stress disorder. This decision comes just months after advisors to the agency voted against evidence supporting MDMA therapy . The agency's decision was ...

That could help establish that the power of MDMA lies in its synergy with trauma-focused therapy. THE BASICS There are other flaws in the FDA’s reasoning, to the extent it can be inferred based ...

Earlier this month the U.S. Department of Veterans Affairs announced it would begin funding research into MDMA-assisted therapy for post-traumatic stress disorder, and the Food and Drug ...

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

This is a big problem — it factored into the Food and Drug Administration's (FDA) decision to reject an MDMA-assisted therapy for PTSD this summer. These shortcomings need to be overcome for ...

Emerson has been at the helm of Lykos since 2014 and has been involved in the development of its MDMA-based midomafetamine therapy for post-traumatic stress disorder (PTSD) for more than 20 years.

Amid psychedelic therapy's legalization in Colorado, veterans implored Colorado Springs officials not to pass treatment ...